Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1966 1
1967 1
1968 1
1974 1
1976 1
1978 1
1979 1
1980 1
1981 1
1982 2
1983 4
1984 3
1985 2
1986 3
1987 2
1988 5
1989 1
1990 4
1991 4
1992 4
1993 4
1994 8
1995 7
1996 5
1997 5
1998 2
1999 7
2000 8
2001 8
2002 3
2003 4
2004 7
2005 5
2006 8
2007 10
2008 8
2009 4
2010 9
2011 6
2012 13
2013 15
2014 11
2015 6
2016 9
2017 8
2018 5
2019 6
2020 13
2021 10
2022 7
2023 10
2024 13
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo.
Dejoux A, Zhu Q, Woolfe A, Godon O, Ellouze S, Mottet G, Castrillon C, Gillis C, Pecalvel C, Ganneau C, Iannascoli B, Lemoine F, Saul F, England P, Reber LL, Gouel-Chéron A, de Chaisemartin L, Haouz A, Millot GA, Bay S, Gérard A, Jönsson F, Chollet-Martin S, Bruhns P. Dejoux A, et al. Among authors: lemoine f. J Allergy Clin Immunol. 2025 Jan 30:S0091-6749(25)00113-7. doi: 10.1016/j.jaci.2025.01.025. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 39892658 Free article.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: lemoine f. Lancet Infect Dis. 2025 Mar;25(3):301-311. doi: 10.1016/S1473-3099(24)00570-X. Epub 2024 Oct 14. Lancet Infect Dis. 2025. PMID: 39419046
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies.
Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, Prot M, Guivel-Benhassine F, Lemoine F, Enouf V, Simon-Loriere E, Mouquet H, Rameix-Welti MA, Schwartz O. Planas D, et al. Among authors: lemoine f. Pathog Immun. 2024 Sep 30;10(1):1-11. doi: 10.20411/pai.v10i1.752. eCollection 2024. Pathog Immun. 2024. PMID: 39391808 Free PMC article.
Online immunology education for a global world.
Vabret N, Mateus-Tique J, Salmon H, Martin JC, Mateo V, Serrano S, Lemoine F, Chammas R, Merad M. Vabret N, et al. Among authors: lemoine f. Nat Rev Immunol. 2024 Sep;24(9):615-616. doi: 10.1038/s41577-024-01066-w. Nat Rev Immunol. 2024. PMID: 38997523 No abstract available.
267 results